Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 2 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Recs

0
Player Avatar pchop123 (80.23) Submitted: 11/8/2012 7:44:40 PM : Underperform Start Price: $1.53 CHTP Score: +3.59

Losing proposition

Featured Broker Partners


Advertisement